Final overall survival and safety update for durvalumab in third- or later-line advanced NSCLC: The phase II ATLANTIC study

Marina Chiara Garassino; Byoung-Chul Cho; Joo-Hang Kim; Julien Mazières; Johan Vansteenkiste; Hervé Lena; Jesus Corral Jaime; Jhanelle E Gray; John Powderly; Christos Chouaid; Paolo Bidoli; Paul Wheatley-Price; Keunchil Park; Ross A Soo; Lynne Poole; Catherine Wadsworth; Phillip A Dennis; Naiyer A Rizvi

doi:10.1016/j.lungcan.2020.06.032

Journal Articles Lung Cancer Year : 2020

Final overall survival and safety update for durvalumab in third- or later-line advanced NSCLC: The phase II ATLANTIC study

(1) , (2) , (3) , (4) , (5) , (6) , , (7) , (8) , (9, 10, 11) , (12) , (13) , (14) , (15) , (16) , (17) , (18) , (19)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19

Marina Chiara Garassino

Function : Author
PersonId : 1265349

IRCCS Istituto Nazionale dei Tumori [Milano]

Byoung-Chul Cho

Function : Author

Yonsei Cancer Center

Joo-Hang Kim

Function : Author

CHA Bundang Medical Center

Julien Mazières

Function : Author

Service Pneumologie-Allergologie [CHU Toulouse]

Johan Vansteenkiste

Function : Author

Department of Pulmonology

Hervé Lena

Function : Author

Chemistry, Oncogenesis, Stress and Signaling

Jesus Corral Jaime

Function : Author

Jhanelle E Gray

Function : Author

H. Lee Moffitt Cancer Center and Research Institute

John Powderly

Function : Author

Carolina BioOncology Institute

Christos Chouaid

Function : Author

Biomécanique cellulaire et respiratoire

Service de Pneumologie [CHI Créteil]

IMRB - CEPIA/"Clinical Epidemiology And Ageing : Geriatrics, Primary Care and Public Health" [Créteil]

Paolo Bidoli

Function : Author

Azienda Ospedaliera San Gerardo

Paul Wheatley-Price

Function : Author

The Ottawa Hospital Research Institute, Centre for Rehabilitation Research and Development, 505 Smyth Road, Ottawa, ON, Canada, K1H 8M2.

Keunchil Park

Function : Author

Samsung Medical Center Sungkyunkwan University School of Medicine

Ross A Soo

Function : Author

National University Hospital and National University Cancer Institute

Lynne Poole

Function : Author

Employed by Eli Lilly & Co at the time the research was performed

Catherine Wadsworth

Function : Author

AstraZeneca [Cambridge, UK]

Phillip A Dennis

Function : Author

AstraZeneca, Gaithersburg

Naiyer A Rizvi

Function : Author

Columbia University [New York]

Keywords

ATLANTIC Durvalumab NSCLC Overall survival Safety

Domains

Cancer

Fichier principal

PIIS0169500220305067.pdf (838.48 Ko)

Origin	Publication funded by an institution

Claudia Tapia : Connect in order to contact the contributor

https://hal.u-pec.fr/hal-04143081

Submitted on : Tuesday, June 27, 2023-2:29:30 PM

Last modification on : Monday, January 22, 2024-12:09:55 PM

Long-term archiving on : Friday, September 29, 2023-4:26:30 PM

Dates and versions

hal-04143081 , version 1 (27-06-2023)

Identifiers

HAL Id : hal-04143081 , version 1
DOI : 10.1016/j.lungcan.2020.06.032

Cite

Marina Chiara Garassino, Byoung-Chul Cho, Joo-Hang Kim, Julien Mazières, Johan Vansteenkiste, et al.. Final overall survival and safety update for durvalumab in third- or later-line advanced NSCLC: The phase II ATLANTIC study. Lung Cancer, 2020, 147, pp.137 - 142. ⟨10.1016/j.lungcan.2020.06.032⟩. ⟨hal-04143081⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-RENNES1 CNRS FNCLCC MARQUIS IMRB UPEC OSS UR1-UFR-SVE UNIV-RENNES UR1-BIO-SA

13 View

16 Download

Final overall survival and safety update for durvalumab in third- or later-line advanced NSCLC: The phase II ATLANTIC study

Keywords

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share